CLOV (Clover Health Investments, Corp) Stock Analysis - Hedge Fund Holdings
Clover Health Investments, Corp (CLOV) is a publicly traded Healthcare sector company. As of May 21, 2026, CLOV trades at $3.59 with a market cap of $1.79B and a P/E ratio of 0.00. CLOV moved +2.57% today. Year to date, CLOV is +38.61%; over the trailing twelve months it is -2.71%. Its 52-week range spans $1.58 to $4.87. Analyst consensus is buy with an average price target of $2.98. Rallies surfaces CLOV's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
Who owns CLOV stock?
Hedge funds tracked by Rallies that own CLOV include Exoduspoint Capital. The latest tracked quarter is Dec 31, 2025. Rallies shows current holdings, share counts, position changes, and 13F ownership context for Clover Health Investments, Corp.
CLOV Key Metrics
Key financial metrics for CLOV
Metric
Value
Price
$3.59
Market Cap
$1.79B
P/E Ratio
0.00
EPS
$0.00
Dividend Yield
0.00%
52-Week High
$4.87
52-Week Low
$1.58
Volume
132
Avg Volume
0
Revenue (TTM)
$2.21B
Net Income
$-56.94M
Gross Margin
0.00%
Top Hedge Funds Holding CLOV
Exoduspoint Capital holds 59.16K shares of CLOV, changed +0.61% as of Dec 31, 2025.
Hedge funds tracked by Rallies that own CLOV include Exoduspoint Capital. The latest tracked quarter is Dec 31, 2025. Rallies shows current holdings, share counts, position changes, and 13F ownership context for Clover Health Investments, Corp.
Does Rallies show 13F holders for CLOV?
Yes. Rallies tracks hedge fund and 13F ownership data for CLOV, including fund names, share counts, latest tracked quarter, and position changes when available.
Is CLOV research on Rallies investment advice?
No. Rallies provides research, data, and educational context for CLOV. It does not provide personalized investment advice.
